Projects per year
Personal profile
Expertise
Thomas Ertveldt is a junior postdoc at the VUB’s Molecular Imaging and Therapy (MITH) research group. He recently concluded his doctoral studies revolving the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s) and immune imaging upon immune intervention. With his research, he aspires to improve knowledge and tools to increase patients response as well as reduce adverse effects to novel therapies such as TRT and immunotherapy.
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
FWOSB80: Combining targeted radionuclide therapy and cancer immunotherapy to advance precision medicine through innovation.
Breckpot, K., Devoogdt, N., D'Huyvetter, M., Keyaerts, M. & Ertveldt, T.
1/11/19 → 31/10/23
Project: Fundamental
Research output
-
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Ceuppens, H., Pombo Antunes, A. R., Navarro, L., Ertveldt, T., Berdal, M., Nagachinta, S., De Ridder, K., Lahoutte, T., Keyaerts, M., Devoogdt, N., Goyvaerts, C., D'Huyvetter, M. & Breckpot, K., 6 Sep 2024, (E-pub ahead of print) In: European Journal of Nuclear Medicine and Molecular Imaging.Research output: Contribution to journal › Article › peer-review
-
Generic semi-automated radiofluorination strategy for single domain antibodies: [18F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-α or folate receptor-α overexpression in cancer
Dierick, H., Navarro, L., Ceuppens, H., Ertveldt, T., Pombo Antunes, A. R., Keyaerts, M., Devoogdt, N., Breckpot, K., D'Huyvetter, M., Lahoutte, T., Caveliers, V. & Bridoux, J., Dec 2024, In: EJNMMI Radiopharmacy and Chemistry. 9, 1, 14 p., 54.Research output: Contribution to journal › Article › peer-review
Open Access -
Sustained release of a human pd-l1 single-domain antibody using peptide-based hydrogels
Heremans, J., Maximilian Awad, R., Bridoux, J., Ertveldt, T., Caveliers, V., Madder, A., Hoogenboom, R., Devoogdt, N., Ballet, S., Hernot, S., Breckpot, K. & Martin, C., Mar 2024, In: European Journal of Pharmaceutics and Biopharmaceutics. 196, 196, 21 p., 114183.Research output: Contribution to journal › Article › peer-review
Open AccessFile81 Downloads (Pure) -
Accepted poster session at ImmunoRad 2023: Targeted alpha therapy using Actinium-225 radiolabeled single domain antibodies induces antigen-specific immune responses and instills immunomodulation both systemically and at the tumor microenvironment
Ertveldt, T., Krasniqi, A., Ceuppens, H., Puttemans, J., Dekempeneer, Y., De Jonghe, K., de Mey, W., Lecocq, Q., De Vlaeminck, Y., Awad, R. M., Goyvaerts, C., De Veirman, K., Morgenstern, A., Bruchertseifer, F., Keyaerts, M., Devoogdt, N., D'Huyvetter, M. & Breckpot, K., 27 Sep 2023.Research output: Unpublished contribution to conference › Poster
-
Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
Zeven, K., De Groof, T. W. M., Ceuppens, H., Awad, R. M., Ertveldt, T., de Mey, W., Meeus, F., Raes, G., Breckpot, K. & Devoogdt, N., 20 Sep 2023, In: Frontiers in Immunology. 14, 1, 16 p., 1268900.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)21 Downloads (Pure)
Prizes
-
Alavi-Mandell Award
Ertveldt, Thomas (Recipient), 4 Apr 2024
Prize: Prize (including medals and awards)
File
Activities
-
Cancer Biotherapy and Radiopharmaceuticals (Journal)
Thomas Ertveldt (Peer reviewer)
1 Oct 2023 → 31 Oct 2023Activity: Publication peer-review and editorial work › Publication peer-review
-
SCK NMA-talk
Thomas Ertveldt (Presenter), Nick Devoogdt (Invited speaker) & Matthias D'Huyvetter (Contributor)
14 Nov 2023Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Development and evaluation of Nanobody tracers for non-invasive nuclear imaging of the next generation immune checkpoint TIGIT
Katty Zeven (Speaker), Timo De Groof (Contributor), Hannelore Ceuppens (Contributor), Robin Maximilian Awad (Contributor), Thomas Ertveldt (Contributor), Geert Raes (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
18 Sep 2023 → 20 Sep 2023Activity: Talk or presentation › Talk or presentation at a conference
-
The development of radiolabeled nanobodies against the next-generation immune checkpoint TIGIT for non-invasive immune phenotyping of tumors
Katty Zeven (Speaker), Timo De Groof (Contributor), Robin Maximilian Awad (Contributor), Wout De Mey (Contributor), Thomas Ertveldt (Contributor), Hannelore Ceuppens (Contributor), Kevin De Jonghe (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
16 Mar 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Noninvasive imaging and inhibition of human programmed death ligand 1 (PD-L1) using nanobody K2 to improve cancer immunotherapy
Robin Maximilian Awad (Contributor), Dora Mugoli Chigoho (Contributor), Katrijn Broos (Contributor), Quentin Lecocq (Contributor), Katty Zeven (Contributor), Thomas Ertveldt (Contributor), Lien De Beck (Contributor), Hannelore Ceuppens (Contributor), Yannick De Vlaeminck (Contributor), Cleo Goyvaerts (Contributor), Steve Schoonooghe (Contributor), Vicky Caveliers (Contributor), Catarina Xavier (Contributor), Jessica Bridoux (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Speaker)
25 Oct 2021 → 26 Oct 2021Activity: Talk or presentation › Talk or presentation at a conference
File
Thesis
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Author: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 Jun 2019Supervisor: Krasniqi, A. (Promotor)
Student thesis: Master's Thesis